Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


HC Wainwright & Co. Maintains Buy on Clovis Oncology, Lowers Price Target to $10


Benzinga | Aug 5, 2021 06:09AM EDT

HC Wainwright & Co. Maintains Buy on Clovis Oncology, Lowers Price Target to $10

HC Wainwright & Co. analyst Edward White maintains Clovis Oncology (NASDAQ:CLVS) with a Buy and lowers the price target from $12 to $10.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC